Roger D. Dansey - 13 May 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ Dansey Roger
Issuer symbol
INO
Transactions as of
13 May 2022
Net transactions value
$0
Form type
4
Filing time
17 May 2022, 16:34:28 UTC
Previous filing
22 Apr 2022
Next filing
30 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +12,000 12,000 13 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -12,000 -33% $0.000000 24,000 13 May 2022 Common Stock 12,000 Direct F1
transaction INO Restricted Stock Unit Award $0 +19,000 $0.000000 19,000 16 May 2022 Common Stock 19,000 Direct F2, F3
transaction INO Common Stock Options Award $0 +28,000 $0.000000 28,000 16 May 2022 Common Stock 28,000 $1.89 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 36,000 restricted stock units is as follows: 12,000 shares vested on May 13, 2022; 12,000 shares will vest on May 13, 2023; 12,000 shares will vest on May 13, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 16, 2023.
F3 This grant was made pursuant to the issuer's non-employee director compensation policy.
F4 Options to vest 100% on May 16, 2023.